
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments that could save their lives
Geneva, 21 March 2016—Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access




